level of complacency, and i think at the government doesn't want to have to revert to plan b, we as a country don't want to be told we have to work from home. we don't want to see any kind of lockdown, then we do need to do those things, washing her hands, opening the windows, not meeting indoors if we don't need to that will make the difference. yes. that will make the difference. yes, we have it in _ that will make the difference. yes, we have it in our— that will make the difference. yes, we have it in our power, _ that will make the difference. yes, we have it in our power, we - that will make the difference. yes, we have it in our power, we have the tests, we have the vaccines. matthew taylor, for the moment, thank you very much for that. in the united states, the fda will decide friday whether to approve a similar booster programme, with the expectation it will get under way as early as next week. but that has given rise to criticism in the united states — and indeed here in the uk — that the west is prioritising vaccines for boosters, while ignoring a chronic shortage of vaccine in the developing world. here's a graph that shows the rate of vaccination by continent, the tiny red sliver at the very top of the screen is africa, which has received just 2% of all vaccines administered globally, for a population of 1.3 billion people. below it in light blue is asia, with some four billion people, they have received 66% percent of the vaccines administered worldwide. there is a huge disparity